ELK1 and hepatocellular carcinoma: Evidence for this mechanism were first reported in HCC in 2005, in a study in which ELK1 and MZF1 antisense oligonucleotides were reported to reduce PRKCA mRNA levels and significantly impair cell proliferation, migration, and invasion [229].